image
Regulus Therapeutics Inc. RGLS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 8.16
0 %
$ 565 M
Market Cap
-12.0
P/E
Price Target Average
--14.22%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
78.87%
Net Income Estimate
62.91%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Regulus Therapeutics Inc.
image
Wall Street analysts predict an average 1-year price target for RGLS of $7 , with forecasts ranging from a low of $7 to a high of $7 .
RGLS Lowest Price Target Wall Street Target
7 USD -14.22%
RGLS Average Price Target Wall Street Target
7 USD -14.22%
RGLS Highest Price Target Wall Street Target
7 USD -14.22%
Price
Max Price Target
Min Price Target
Average Price Target
99887766554433221100Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart RGLS

image
$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.020152015201620162017201720182018201920192020202020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RGLS

image
$450.0m$450.0m$400.0m$400.0m$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)20152015201620162017201720182018201920192020202020232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RGLS

image
$500.0m$500.0m$0.0$0.0($500.0m)($500.0m)($1.0b)($1.0b)($1.5b)($1.5b)($2.0b)($2.0b)($2.5b)($2.5b)($3.0b)($3.0b)($3.5b)($3.5b)20152015201620162017201720182018201920192020202020232023202420242025202520262026202720272028202820292029